Gut microbiome composition influences estrogen metabolism and hormonal balance
Static snapshot — vote, comment, and submit papers on the live app.
Open in Live App →- Inconclusive
Gut Microbiome–Estrobolome Profile in Reproductive-Age Women with Endometriosis
Published 2023Reviewer Insight6/5/2026This study found that women with endometriosis had higher levels of four fecal estrogen metabolites and greater abundance of Erysipelotrichia bacteria compared to controls, but the key enzymatic link — β-glucuronidase activity — showed no difference between groups. These findings are not reliable enough to support the claim, for the following reasons:
- Hormone medication imbalance: 7 patients in the endometriosis group vs. 1 control received GnRH agonists or progestins shortly before sample collection — these drugs directly alter both estrogen levels and gut bacteria, making it impossible to attribute the metabolite differences to the gut microbiome
- No correction for multiple tests: The study tested 14 estrogen compounds using a threshold designed for a single test; when corrected properly, none of the "significant" metabolite results hold up
- The proposed mechanism was absent: The enzyme (β-glucuronidase) that supposedly links gut bacteria to estrogen recycling showed no difference between groups
- Small sample, high individual variation: With only 51 participants and more variation within groups than between them, the study lacks the power to draw firm conclusions
- Tested in Humans
Gut microbiome in endometriosis: a cohort study on 1000 individuals
Published 2024Reviewer Insight6/5/2026This large study used advanced DNA sequencing of stool samples from 1,000 women — including 136 with confirmed endometriosis — to test whether the gut microbiome (especially estrogen-processing enzymes called the estrobolome) differs between women with and without endometriosis. Across every analysis, no meaningful differences were found after proper statistical correction, directly contradicting the idea that gut bacteria drive hormonal imbalance in this condition.
- The study specifically measured 156 estrogen-metabolizing enzymes and found no significant differences — the most direct test of the claim
- Results held up in a sensitivity analysis restricted to reproductive-age women, making menopausal effects an unlikely explanation
- A key caveat: many endometriosis patients were on hormonal treatment (which is known to normalize gut bacteria), potentially masking a real underlying difference in untreated disease
- The Estonian-only population limits how broadly these results apply to other groups
- The claim remains plausible in theory, but this study — the largest of its kind — provides no supporting evidence for it in practice
Snapshot built: 2026-06-19